OncBioMune Pharmaceuticals, Inc (62) | Consulting Agreements (2)
- Consulting Agreement between OncBioMune Pharmaceuticals, Inc. and Andrew Kucharchuk effective January 1, 2021 (Filed With SEC on January 13, 2022)
- Consulting Agreement between OncBioMune Pharmaceuticals, Inc. and Andrew Kucharchuk dated June 5, 2020 (Filed With SEC on June 11, 2020)
